Lucy Xi pleaded guilty to stealing trade secrets from GlaxoSmithKline (GSK) to the benefit of a Chinese pharmaceutical company, Renopharma. Xi, one of five co-defendants created the company, Renopharma, with the purpose of researching anti-cancer drugs. The Department of Justice noted that the reality was that the company received funding from China and that the company was nothing more than a “repository of information stolen from GSK.”
Three of the co-defendants (Yu Xue, Tain Xu and Tao Li) had previously pleaded guilty to their roles in the theft of intellectual property from GSK, with Yan Mei (the fifth defendant and husband to Lucy Xi) is believed to be absconding in Nanjing, China.
Lucy Xi and Yu Xue, were employees of GSK. Court documents indicate that Yu Xue, her twin sister Tian Xue, and Tao Li all received their PhDs from the University of North Carolina. While Yan Mei received his PhD from the University of Iowa. Xi sent her husband an e-mail which contained the summary of GSK research into monoclonal antibodies, the body of the mail said, “You need to understand it very well. It will help you in your future business [Renopharma]. The GSK facility in Upper Merion, PA, worked on developing biopharmaceutical products which, typically cost in excess of $1 billion to research and develop.
As this was a prime example of insider theft for personal gain, it would be prudent for the University of North Carolina to review the research which was conducted by Yu Xue, Tian Xue and Tao Li to determine if intellectual property theft had occurred and the University of Iowa to review if Yan Mei purloined research during his time at the University.
U.S. Attorney, Jennifer Arbittier Williams, said, “This defendant illegally stole trade secrets to benefit her husband’s company, which was financed by the Chinese government. The lifeblood of companies like GSK is its intellectual property, and when that property is stolen and transferred to a foreign country, it threatens thousands of American jobs and jeopardizes the strategic benefits brought about through research and development. Such criminal behavior must be prosecuted to the fullest extent of the law.”
Sentencing for Luxy Xi will be in April 2022.
Contact ITMG to Develop Strategies and Protocols Designed to Help Your Company Mitigate Your Insider Risk
ITMG is an industry leader in helping organizations throughout the United States strengthen their insider risk management programs and secure sensitive data and intellectual property. Our team of bona fide experts has the real-world experience necessary to plan out and create holistic security solutions tailored to the needs and risks in your industry. Contact ITMG today to learn more about how we can help! You can also visit our Facebook, Twitter, and LinkedIn pages for more updates and insights into the world of insider risk management.
